Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway

BACKGROUND: VEGF signaling pathway inhibitor (anti-VEGF) therapy is associated with hypertension, but little is known about predisposing clinical characteristics. This study describes the real-world association between baseline clinical characteristics, blood pressure (BP) response, and survival in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Hamnvik, Ole-Petter R., Choueiri, Toni K., Turchin, Alexander, McKay, Rana R., Goyal, Lipika, Davis, Michael, Kaymakcalan, Marina D., Williams, Jonathan S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293233/
https://ncbi.nlm.nih.gov/pubmed/25236375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28972
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky